A huge federal trial of personalized cancer medicine has run into an unexpected roadblock: Many of the tumor samples aren¹t robust enough to be put through genetic analysis. Keith Flaherty (Mass General) is leading the trial.
Trending News
Search for Babesiosis Treatment Gets a New Map
New clues to help fight tick-borne disease
Can an AI ‘Co-Scientist’ Accelerate Cancer Research?
Nearly $7 million funds agentic AI tools to assist investigations into cancer’s most pressing…
First Large-Scale Study Shows How Doctors Use AI in Medicine
Which practitioners use artificial intelligence in the clinic, and what do they ask?